Table 2.
The relationships between DHX9 levels and clinicopathological characteristics in lung cancer tissues
| Parameters | Total | Expression levels of DHX9 | P value | |||
|---|---|---|---|---|---|---|
|
| ||||||
| - | + | ++ | +++ | |||
| All case | 45 | 7 | 5 | 16 | 17 | |
| Age | ||||||
| < 60 | 24 | 6 | 1 | 10 | 7 | |
| ≥ 60 | 21 | 1 | 4 | 6 | 10 | 0.194 |
| Gender | ||||||
| Male | 31 | 3 | 5 | 10 | 13 | |
| Female | 14 | 4 | 0 | 6 | 4 | 0.365 |
| Histology | ||||||
| Control | 16 | 13 | 3 | 0 | 0 | |
| Lung cancer | 45 | 7 | 5 | 16 | 17 | 0.000*** |
| LSCC | 12 | 3 | 3 | 4 | 2 | |
| Lung adenocarcinoma | 33 | 4 | 2 | 12 | 15 | 0.034* |
| Lymphatic invasion | ||||||
| N0 | 24 | 5 | 2 | 8 | 9 | |
| N+ | 21 | 2 | 3 | 8 | 8 | 0.719 |
| TNM stage | ||||||
| I+II | 33 | 7 | 2 | 12 | 12 | |
| III+IV | 12 | 0 | 3 | 2 | 5 | 0.467 |
*
P < 0.05;
***
P < 0.001.